Transcriptional targets of the schizophrenia risk gene MIR137

Translational Psychiatry

Volumn 4, Issue , 2014, Pages

  Collins, A L ^a   Kim, Y ^a   Bloom, R J ^a   Kelada, S N ^a   Sethupathy, P ^a   Sullivan, P F ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; MICRORNA; MICRORNA 137; RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; HIGH THROUGHPUT SEQUENCING; HISTOCOMPATIBILITY COMPLEX; HUMAN; HUMAN CELL; NEURAL STEM CELL; RNA SEQUENCE; SCHIZOPHRENIA; SYNAPSE;

EID: 84902650645     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.42     Document Type: Article

References (64)

1. Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological Insights From 108 Schizophrenia-Associated Genetic Loci. Nature 2014.
2. Levinson DF, Duan J, Oh S, Wang K, Sanders AR, Shi J et al. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry 2011; 168: 302-316.
3. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P et al. A burden of ultra-rare disruptive mutations concentrated in synaptic gene networks increases risk of schizophrenia. Nature 2014; 506: 185-190.
4. Fromer M, Pocklington AJ, Kavanagh D, Williams H, Dwyer S, Gormley P et al. De novo mutations in schizophrenia identify pathogenic gene networks regulating synaptic strength and overlap with autism and intellectual disability. Nature 2014; 506: 179-184.
5. Ripke S, Sanders AR, Kendler KS, Levinson DF, Sklar P, Holmans PA et al. Genomewide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969-976.
6. Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kahler AK, Akterin S et al. Genomewide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013; 45: 1150-1159.
7. Guella I, Sequeira A, Rollins B, Morgan L, Torri F, van Erp TG et al. Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. J Psychiatr Res 2013; 47: 1215-1221.
8. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
9. Carrington JC, Ambros V. Role of microRNAs in plant and animal development. Science 2003; 301: 336-338.
10. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769-773.
11. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455: 58-63.
12. Tarantino C, Paolella G, Cozzuto L, Minopoli G, Pastore L, Parisi S et al. miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells. FASEB J 2010; 24: 3255-3263.
13. Smrt RD, Szulwach KE, Pfeiffer RL, Li X, Guo W, Pathania M et al. MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb- 1. Stem Cells 2010; 28: 1060-1070.
14. Szulwach KE, Li X, Smrt RD, Li Y, Luo Y, Lin L et al. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol 2010; 189: 127-141.
15. Sun G, Ye P, Murai K, Lang MF, Li S, Zhang H et al. miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells. Nat Commun 2011; 2: 529.
16. Devanna P, Vernes SC. A direct molecular link between the autism candidate gene RORa and the schizophrenia candidate MIR137. Sci Rep 2014; 4: 3994.
17. Willemsen MH, Valles A, Kirkels LA, Mastebroek M, Olde Loohuis N, Kos A et al. Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability. J Med Genet 2011; 48: 810-818.
18. Wu H, Tao J, Chen PJ, Shahab A, Ge W, Hart RP et al. Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome. Proc Natl Acad Sci USA 2010; 107: 18161-18166.
19. Geekiyanage H, Chan C. MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid {beta}, novel targets in sporadic Alzheimer's disease. J Neurosci 2011; 31: 14820-14830.
20. Soldati C, Bithell A, Johnston C, Wong KY, Stanton LW, Buckley NJ. Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington's disease. J Neurochem 2013; 124: 418-430.
21. Langevin SM, Stone RA, Bunker CH, Grandis JR, Sobol RW, Taioli E. MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. Carcinogenesis 2010; 31: 864-870.
22. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 2009; 125: 2737-2743.
23. Dacic S, Kelly L, Shuai Y, Nikiforova MN. miRNA expression profiling of lung adenocarcinomas: correlation with mutational status. Mod Pathol 2010; 23: 1577-1582.
24. Zhi F, Chen X, Wang S, Xia X, Shi Y, Guan W et al. The use of hsa-miR-21, hsamiR- 181b and hsa-miR-106a as prognostic indicators of astrocytoma. Eur J Cancer 2010; 46: 1640-1649.
25. Liu M, Lang N, Qiu M, Xu F, Li Q, Tang Q et al. miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells. Int J Cancer 2011; 128: 1269-1279.
26. Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, Boland CR et al. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res 2010; 70: 6609-6618.
27. Chen X, Wang J, Shen H, Lu J, Li C, Hu D et al. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. Invest Ophthalmol Vis Sci 2010; 52: 1193-1199.
28. Chen Q, Chen X, Zhang M, Fan Q, Luo S, Cao X. miR-137 is frequently downregulated in gastric cancer and is a negative regulator of Cdc42. Dig Dis Sci 2011; 56: 2009-2016.
29. Sethupathy P, Megraw M, Hatzigeorgiou AG. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods 2006; 3: 881-886.
30. Witkos TM, Koscianska E, Krzyzosiak WJ. Practical aspects of microRNA target prediction. Curr Mol Med 2011; 11: 93-109.
31. Haflidadottir BS, Bergsteinsdottir K, Praetorius C, Steingrimsson E. miR-148 regulates Mitf in melanoma cells. PLoS ONE 2010; 5: e11574.
32. Bemis LT, Chen R, Amato CM, Classen EH, Robinson SE, Coffey DG et al. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res 2008; 68: 1362-1368.
33. Kwon E, Wang W, Tsai LH. Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets. Mol Psychiatry 2013; 18: 11-12.
34. Kim AH, Parker EK, Williamson V, McMichael GO, Fanous AH, Vladimirov VI. Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137. Schizophr Res 2012; 141: 60-64.
35. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008; 455: 1124-1128.
36. Schnall-Levin M, Zhao Y, Perrimon N, Berger B. Conserved microRNA targeting in Drosophila is as widespread in coding regions as in 3′UTRs. Proc Natl Acad Sci USA 2010; 107: 15751-15756.
37. Donato R, Miljan EA, Hines SJ, Aouabdi S, Pollock K, Patel S et al. Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci 2007; 8: 36.
38. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009; 25: 1105-1111.
39. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010; 28: 511-515.
40. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003; 100: 9440-9445.
41. Wright F, Sullivan PF, Brooks AI, Zou F, Sun W, Xia K et al. Heritability and genomics of gene expression in periferal blood. Nat Genet 2014; 46: 430-437.
42. Bartonicek N, Enright AJ. SylArray: a web server for automated detection of miRNA effects from expression data. Bioinformatics 2010; 26: 2900-2901.
43. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
44. Rossin EJ, Lage K, Raychaudhuri S, Xavier RJ, Tatar D, Benita Y et al. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet 2011; 7: e1001273.
45. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
46. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009; 37: 1-13.
47. Gene Ontology Consortium. The gene ontology: enhancements for 2011. Nucleic Acids Res 2012; 40: D559-D564.
48. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2012; 40: D109-D114.
49. Levy S, Hannenhalli S. Identification of transcription factor binding sites in the human genome sequence. Mamm Genome 2002; 13: 510-514.
50. Sethupathy P, Giang H, Plotkin JB, Hannenhalli S. Genome-wide analysis of natural selection on human cis-elements. PLoS ONE 2008; 3: e3137.
51. Hill MJ, Donocik JG, Nuamah RA, Mein CA, Sainz-Fuertes R, Bray NJ. Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells. Schizophr Res 2014; 153: 225-230.
52. Sanders AR, Goring HH, Duan J, Drigalenko EI, Moy W, Freda J et al. Transcriptome study of differential expression in schizophrenia. Hum Mol Genet 2013; 22: 5001-5014.
53. Ruano D, Abecasis GR, Glaser B, Lips ES, Cornelisse LN, de Jong AP et al. Functional gene group analysis reveals a role of synaptic heterotrimeric G proteins in cognitive ability. Am J Hum Genet 2010; 86: 113-125.
54. Croning MD, Marshall MC, McLaren P, Armstrong JD, Grant SG. G2Cdb: the genes to cognition database. Nucleic Acids Res 2009; 37: D846-D851.
55. Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 2012; 17: 142-153.
56. Muller CS, Haupt A, Bildl W, Schindler J, Knaus HG, Meissner M et al. Quantitative proteomics of the Cav2 channel nano-environments in the mammalian brain. Proc Natl Acad Sci USA 2010; 107: 14950-14957.
57. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011; 146: 247-261.
58. Lee PH, O'Dushlaine C, Thomas B, Purcell S. InRich: Interval-based enrichment analysis for genome-wide association studies. Bioinformatics 2012; 28: 1797-1799.
59. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 2008; 6: 14.
60. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D et al. Common variants conferring risk of schizophrenia. Nature 2009; 460: 744-747.
61. Irish Schizophrenia Genomics Consortium, Wellcome Trust Case Control Consortium. Genome-wide association study implicates HLA-C*01:02 as a risk factor at the MHC locus in schizophrenia. Biol Psychiatry 2012; 72: 620-628.
62. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 2006; 34: D108-D110.
63. Lips ES, Cornelisse LN, Toonen RF, Min JL, Hultman CM, Holmans PA et al. Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. Mol Psychiatry 2012; 17: 996-1006.
64. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008; 40: 1056-1058.